Market Recap

Post-Market Analysis

This report provides an in-depth and comprehensive summary of critical market-moving intraday and after-hours news. Furthermore, it offers a detailed breakdown of material corporate disclosures, specifically focusing on key 6-K and 8-K SEC filings, alongside a thorough analysis of zero-days-to-expiration (0DTE) options data to gauge immediate market sentiment and volatility.

06/01/2026 7:16:12 PM ET

2026-06-01 Post-market Analysis Report

U.S. equity markets opened with modest gains—Dow Jones up 46 points, S&P 500 and Nasdaq rising 0.3% and 0.4% respectively—amid mixed global signals. MGM Resorts surged 16% following a $12.4 billion acquisition bid from Barry Diller, highlighting demand for entertainment/hospitality assets. Tech outperformed, driven by AI investment expectations, while geopolitical tensions in the Middle East introduced market uncertainty and pushed crude oil prices up 5.73% to $92.37/barrel. Anthropic’s IPO filing and significant AI investments from Alphabet and Berkshire Hathaway fueled enthusiasm in the AI sector, with Nvidia benefiting from hardware demand. Sun Communities plans to sell its UK platform to focus on North American manufactured housing and RV communities, anticipating 4.7% NOI growth in 2026. SVC transitioned to an earnings recovery phase with a $1.6 billion capital markets activity, focusing on net lease properties and renovations. Bank of Marin shareholders approved board elections and auditor ratification. WEC Energy Group continues to demonstrate consistent earnings growth, investing $12.6 billion through 2030 in renewables and infrastructure. A company reported low default rates, consistent rent growth, and a conservative debt structure, emphasizing service-oriented tenants and long-term leases. Manhattan Associates will reduce its workforce by 6% to improve efficiency, incurring $7-9 million in costs, while acknowledging geopolitical and technological risks.

05/29/2026 7:15:29 PM ET

2026-05-29 Post-market Analysis Report

U.S. equity markets experienced modest gains, extending a weekly recovery despite mixed economic signals. The S&P 500 and Nasdaq approached record highs, driven by growth sectors, while the Dow lagged. Corporate earnings were varied, with technology and energy outperforming, exemplified by Dell’s 33% surge fueled by AI demand. Conversely, aerospace and automotive faced challenges, including a Blue Origin rocket failure. A widening gap between corporate profits (up 2.7%) and labor’s share of income (down to 49%) raises concerns about equitable economic growth. Geopolitical factors, including Middle East tensions and Canada’s recession, added complexity. Market activity shows increased risk appetite with rising junk bond demand. Several companies reported updates: Lisata Therapeutics amended its merger terms, Seanergy Maritime declared a dividend and expanded its fleet, KeyCorp highlighted strong deposit bases and growth potential, FG Merger II Corp. secured funding via a forward purchase agreement, Cardiff Oncology initiated legal action regarding patent inventorship, Alterity Therapeutics gained shareholder approval for a pivotal Phase 3 trial, Aspen Insurance announced preference share dividends, Palomar Holdings strengthened its reinsurance program, E\Trade faces ongoing litigation, TOP Ships amended debt and option agreements, and TOP Ships amended debt and option agreements. These developments underscore a market balancing optimism with underlying economic and geopolitical uncertainties.

05/28/2026 7:08:49 PM ET

2026-05-28 Post-market Analysis Report

Ionis Pharmaceuticals reported positive pivotal trial data for bepirovirsen, an investigational hepatitis B treatment developed with GSK. Results published in the New England Journal of Medicine showed a statistically significant 19% functional cure rate after six months in patients with lower viral loads, dramatically exceeding current treatment efficacy. A 26% cure rate was observed in patients with the lowest viral loads, representing a significant portion of the global patient population. Long-term data indicated sustained undetectable viral levels in nearly half of participants one year post-treatment. The drug demonstrated an acceptable safety profile. Bepirovirsen is currently under priority review by the FDA and regulatory bodies globally, with Ionis poised to receive milestone payments and royalties on potential sales under its licensing agreement with GSK.

05/27/2026 7:37:57 PM ET

2026-05-27 Post-market Analysis Report

Markets navigated a mixed session shaped by geopolitical tensions, particularly around Iran’s nuclear negotiations which drove a 5.31% drop in Brent crude oil. The Dow edged up 0.4% on defensive sector strength, while the S&P 500 and Nasdaq were largely flat, reflecting uncertainty. Tech stocks faced pressure as semiconductor valuations were reassessed amid demand concerns. Private credit markets showed vulnerability with redemption pressures at Vista Credit Strategic Lending. The US 10-year Treasury yield fell amidst uncertainty, while JPMorgan Chase explored potential acquisitions and SpaceX faced regulatory scrutiny. AMSC reported record revenue and a significant backlog, projecting continued growth. Colliers International acquired Ayesa Engineering, expanding its global engineering footprint. Abercrombie & Fitch posted record sales, maintaining a positive outlook despite EMEA headwinds. Braze saw 30.2% revenue growth driven by AI-powered customer engagement. Marvell Technology achieved record revenue, boosted by acquisitions and AI demand. Sleep Number shareholders rejected proposals to declassify the board and eliminate supermajority voting. Finally, Fold Holdings retracted a press release announcing a credit facility, stating no agreement is currently in place.

05/26/2026 6:28:24 PM ET

2026-05-26 Post-market Analysis Report

Equity markets showed resilience with tech stocks leading gains; the S&P 500 rose 0.6%, Nasdaq 1.2%. Micron & ON Semiconductor surged on AI/chip demand. Bond yields fell slightly (10-yr Treasury -0.08% to 4.49%) amid Fed policy uncertainty. Oil prices diverged—Brent up 3.58%, WTI down 2.81%—reflecting geopolitical risk. BP removed its Chairman following misconduct allegations, appointing its first female CEO. Ferrari’s EV concept faced criticism, causing an 8.4% stock decline. Investor risk appetite is high, with equity risk premium near lows. Aura Minerals presents a strong investment opportunity with 6 operating mines, 1.751M GEO reserves, and a history of shareholder returns. Semtech reported record Q1 FY27 results with 16% YoY net sales growth driven by data center & LoRa demand. Pembina Pipeline sanctioned the $570M Heartland Extraction Plant, securing a long-term ethane supply agreement with Dow and supporting 5-7% EBITDA growth. Silexion Therapeutics enacted a 1-for-10 reverse stock split, Patterson-UTI anticipates strong Q2 2026 EBITDA, Amerigas Partners issued a Senior Notes Indenture, Destination XL rejected a tender offer, Microbot Medical received Israeli regulatory approval for its robotic system, and TEN Holdings completed a private placement while addressing Nasdaq compliance issues.